SOLTF (Nxera Pharma Co) Short Percentage of Float

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SOLTF Nxera Pharma Co Ltd SOLTF
82 GF Score
Price $5.01
GF Value $4.13
Valuation Modestly Overvalued
! 7 Warning Signs
View Full Analysis

What is Nxera Pharma Co Short Percentage of Float?

Short Percentage of Float is the percentage of shares shorted compared to the float.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

SOLTF vs VRTX, REGN, RVMD: Short Percentage of Float Comparison

For the Biotechnology subindustry, Nxera Pharma Co's Short Percentage of Float, along with its competitors' market caps and Short Percentage of Float data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Nxera Pharma Co Short Percentage of Float vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Nxera Pharma Co's Short Percentage of Float distribution charts can be found below:

* The bar in red indicates where Nxera Pharma Co's Short Percentage of Float falls into.


SOLTF
82GF Score
Nxera Pharma Co Ltd SOLTF
Short Percentage of Float is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Nxera Pharma Co (SOLTF) Overvalued in 2026?

Based on GuruFocus' analysis, Nxera Pharma Co stock appears to be overvalued. The current stock price of $5.01 is trading 21.3% above its estimated GF Value™ of $4.13. GuruFocus considers Nxera Pharma Co to be Modestly Overvalued.

Key valuation signals for SOLTF:

  • Short Percentage of Float:
  • GF Value™: $4.13 vs. price of $5.01 (21.3% above fair value)
  • GF Score™: 82/100 with 7 warning signs

No single metric tells the full story. See the SOLTF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Nxera Pharma Co Business Description

Other Exchanges 4565:Japan
Address Midtown East, 9-7-2 Akasaka Minato-ku, Tokyo, JPN, 107-0052
Nxera Pharma Co Ltd is a science and technology-led biopharmaceutical company. Its activities are drug discovery, drug development and the commercialization of pharmaceutical products. The focus is to discover new medicines for unmet medical needs, including novel small molecules, peptides and therapeutic antibodies targeting G Protein Coupled Receptors (GPCRs).
82GF Score

Get the complete analysis for SOLTF

Short Percentage of Float is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$5.01
Price
$4.13
GF Value